MEDP Medpace Holdings, Inc.
Company Analysis
Latest News
Medpace Holdings authorizes $1 billion share repurchase program in third quarter 2026
Medpace Holdings reported its third quarter 2026 results, highlighting a major update to its capital allocation strategy. While the primary financial results...
🟢 Medpace Holdings is trading 4.42% up today amid a 2.12% healthcare-sector gain
Medpace Holdings is trading at $649.97, up 4.42%, amid healthcare-sector strength; the sector is up 2.12% during the regular session. - Investors are also...
Medpace Holdings Inc Q3 2026 Earnings Preview: What Analysts Expect on October 21, 2026
Consensus expectations for Q3 2026 include revenue of $714.47 million and EPS of $4.45, while the current stock price of $618.47 trades slightly above the...
🔴 Medpace Holdings is trading 6.18% down in pre-market — cause unconfirmed
Medpace Holdings is trading at $565.61, down -6.18% versus the prior close; no confirmed catalyst has been identified for the October 7, 2026 pre-market...
🟢 Medpace Holdings is trading 7.8% up in pre-market — cause remains unconfirmed
Medpace Holdings is trading 7.8% up in pre-market at $668.74, with the cause of the move unconfirmed. - The price compares with the October 5 close of...
🟢 Medpace Holdings is trading 4.05% up today amid higher markets; direct cause unconfirmed
Medpace Holdings is trading at $623.75, up 4.05%, as higher major indexes may be supporting the move; no direct cause is confirmed. - No confirmed...
🟢 Medpace Holdings is trading 4.8% up in pre-market; reason remains unclear
Medpace Holdings is trading up 4.8% in pre-market at $628.36, with no confirmed catalyst identified. - This compares with the October 2 close of $599.47; the...
🔴 Medpace Holdings is trading 4.2% down today amid healthcare weakness and rising Treasury yields
Medpace Holdings is trading 4.2% lower at $597.98, amid healthcare-sector weakness and broader pressure from sharply higher Treasury yields. - No clear...
Medpace CEO Sells $27.4 Million in Stock Over Two Days
Medpace Holdings President and CEO August J. Troendle sold approximately $27.4 million worth of company stock over two days. The transactions were disclosed in...
🔴 Medpace Holdings is trading 28.53% down in after-hours trading with no confirmed catalyst
Medpace Holdings is trading 28.53% lower at $450.41 after closing at $630.19 in the regular session on September 22, 2026, with no confirmed company-specific...
🔴 Medpace Holdings is trading 32.11% down in pre-market; no confirmed catalyst
Medpace Holdings is trading at $423.76 (-32.11%) in pre-market, with no confirmed catalyst. - No confirmed company-specific announcement, earnings release,...
🟢 Medpace Holdings is trading 4% up today on defensive healthcare-sector strength
Medpace Holdings is trading at $619.60, up +4.06% as defensive healthcare-sector strength supports the move. - No major company-specific announcement or...
Medpace Shares Sink, CEO Sells $10 Million Amid Valuation Fears
Medpace Holdings shares fell on August 27, 2026. CEO August Troendle sold approximately $10 million in company stock. The transaction fueled investor concerns...
🟢 Medpace Holdings is trading 6.4% up in pre-market amid broader risk-on sentiment after Nvidia’s strong results
Medpace Holdings is trading at $658.43 (+6.36%) in pre-market, mainly amid broader risk-on sentiment after Nvidia’s strong results. - No clearly reported...
🔴 Medpace Holdings is trading 8.3% down in pre-market amid valuation concerns and profit-taking
Medpace Holdings is trading 8.3% down now at $541.62 in pre-market as broad risk-off selling continued following the August 18, 2026 technology-led market...
🔴 Medpace Holdings is trading 18.85% down in after-hours trading amid broad risk-off selling
Medpace Holdings is trading 18.85% down at $479 now after broad risk-off selling, following the regular session close at $590.30 on August 18, 2026. - The...
🔴 Medpace Holdings is trading 5% down in pre-market as Nasdaq Composite is down 1.12%
Medpace Holdings is trading at $565.00 (-5.38%) in pre-market as weaker markets pressure equities. - The Nasdaq Composite is down 1.12%, with broader risk...
🟢 Medpace Holdings is trading 46% up in pre-market with no company-specific catalyst identified
Medpace Holdings is trading 45.88% up at $848.93 in pre-market after no company-specific announcement dated August 14, 2026 was identified. - Recent coverage...
Medpace faces legal investigations, over alleged inflated growth projections
Bronstein, Gewirtz & Grossman, LLC and Kuehn Law, PLLC launched investigations into Medpace Holdings on August 10, 2026. The probes examine whether the company...
🔴 Medpace Holdings is trading 14.5% down today despite no company-specific news amid broader market weakness
Medpace Holdings is trading at $500.00 (-14.52%) in after-hours trading despite no company-specific earnings release, guidance update, or major announcement...